Brands M W, Hall J E
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216.
J Am Soc Nephrol. 1992 Nov;3(5):1064-77. doi: 10.1681/ASN.V351064.
Recent work to elucidate the cause of obesity-associated hypertension has focused on insulin resistance and hyperinsulinemia. A significant amount of epidemiologic and correlational evidence suggests a link between these factors and obesity-associated hypertension, and acute insulin infusion studies have revealed renal, neural, and cardiovascular effects of this hormone that, if maintained chronically, could cause hypertension. However, correlations and acute effects may not reliably predict a chronic cause-and-effect relationship, and the fundamental question of whether chronic increases in plasma insulin concentration per se can produce a sustained increase in arterial pressure has not been completely resolved. Recent studies designed to address this question directly have found no evidence of a hypertensive effect of insulin in normal dogs, or in dogs with a 70% reduction in kidney mass and given a high sodium intake. Chronic hyperinsulinemia also did not potentiate the pressor effects of angiotensin II or norepinephrine. In fact, hyperinsulinemia caused significant reductions in total peripheral vascular resistance in dogs and a decrease in arterial pressure. Furthermore, induction of insulin resistance in dogs made obese by being fed a high-fat diet eliminated the decrease in peripheral vascular resistance during chronic insulin infusion but did not uncover a pressor effect of hyperinsulinemia. In contrast, insulin infusion for up to 7 days produced a sustained increase in arterial pressure in rats. Although the mechanism for this pressor response is unknown, these data indicate either that there are major species differences in the chronic blood pressure response to insulin or that specific, presently unknown, conditions must exist in order for insulin to raise blood pressure. Also, it is not clear whether humans respond more like rats or dogs with respect to blood pressure changes during chronic hyperinsulinemia. However, it is apparent that obesity hypertension is probably much too complex to be ascribed to insulin resistance and hyperinsulinemia alone.
近期旨在阐明肥胖相关性高血压病因的研究聚焦于胰岛素抵抗和高胰岛素血症。大量的流行病学及相关性证据表明这些因素与肥胖相关性高血压之间存在联系,并且急性胰岛素输注研究已经揭示了该激素对肾脏、神经及心血管系统的影响,若长期存在这些影响,可能会导致高血压。然而,相关性及急性影响可能无法可靠地预测慢性因果关系,血浆胰岛素浓度的慢性升高本身是否会导致动脉压持续升高这一基本问题尚未完全解决。近期旨在直接解决该问题的研究未发现胰岛素对正常犬或肾质量减少70%且高钠摄入的犬有升压作用的证据。慢性高胰岛素血症也未增强血管紧张素II或去甲肾上腺素的升压作用。事实上,高胰岛素血症使犬的总外周血管阻力显著降低,动脉压下降。此外,通过高脂饮食使犬肥胖从而诱导胰岛素抵抗,消除了慢性胰岛素输注期间外周血管阻力的降低,但未发现高胰岛素血症的升压作用。相比之下,对大鼠输注胰岛素长达7天会使动脉压持续升高。尽管这种升压反应的机制尚不清楚,但这些数据表明,要么在胰岛素慢性血压反应方面存在主要的物种差异,要么必须存在特定的、目前未知的条件才能使胰岛素升高血压。同样,在慢性高胰岛素血症期间,人类在血压变化方面是更像大鼠还是更像犬尚不清楚。然而,显然肥胖性高血压可能过于复杂,不能仅归因于胰岛素抵抗和高胰岛素血症。